Influence of parainfluenza‐1 respiratory tract viral infection on endothelin receptor‐effector systems in mouse and rat tracheal smooth muscle
Authors: Knott Patrick G. , Henry Peter J. , McWilliam Andrew S. , Rigby Paul J. , Fernandes Lynette B. , Goldie Roy G. 
Published: July 2012

In this study we have compared the effects of parainfluenza‐1 respiratory tract viral infection on the density and function of ETA and ETB receptors in rat and mouse tracheal airway smooth muscle.
The bronchoconstrictor effect of inhaled methacholine was significantly enhanced in virus‐infected rats, at both 4 and 12 days post‐inoculation. That is, the concentration of methacholine causing an increase in resistance of 100% (PC100 methacholine) was significantly lower in virus‐infected animals at both 4 and 12 days post‐inoculation (n = 6–8; P < 0.05).
Total specific binding of [125I]‐endothelin‐1 and the relative proportions of ETA and ETB binding sites for [125I]‐endothelin‐1 were assessed in tracheal airway smooth muscle in parainfluenza‐1‐infected rats and mice at days 2, 4 and 12 post‐inoculation using the ligands BQ‐123 (1 μm; ETA receptor‐selective) and sarafotoxin S6c (100 nM; ETB receptor‐selective). Total specific binding in mice was significantly reduced at day 2 post‐inoculation (n = 5; P < 0.05) but not at days 4 and 12 post‐inoculation (n = 5). In control mice, the proportions of ETA and ETB binding sites were 53%:47% at day 2 and 43%:57% at day 4 and these were significantly altered by parainfluenza‐1 infection such that, the ratios were 81%:19% at day 2 and 89%:11% at day 4 (P < 0.05). By day 12 post‐inoculation, the proportion of ETA and ETB binding sites in tracheal smooth muscle from mice infected with parainfluenza‐1 was not significantly different from control. In rat tracheal airway smooth muscle, neither total specific binding nor the ETA and ETB binding site ratio (64%:36%) were significantly altered in virus‐inoculated rats at days 2, 4 or 12 post‐inoculation (n = 5).
Parainfluenza‐1 infection in mice had no effect on the sensitivity or maximal contractile effect of endothelin‐1 in tracheal smooth muscle at days 2, 4 or 12 post‐inoculation (n = 4). In contrast, contraction in response to the ETB receptor‐selective agonist sarafotoxin S6c was attenuated by 39% at day 2 and by 93% at day 4 post‐inoculation (P < 0.05). However, by day 12 post‐inoculation, contractions to sarafotoxin S6c were not significantly different between control and virus‐infected mice. In parainfluenza‐1‐infected rats, there were small but significant reductions in the sensitivity to carbachol, endothelin‐1 and sarafotoxin S6c whilst the maximal responses to the highest concentrations of these agonists were not significantly altered by virus infection (n = 8).
BQ‐123 (3 μm) had no significant effect on cumulative concentration‐effect curves to endothelin‐1 in tracheal preparations from control mice (n = 4) or parainfluenza‐1‐infected rats (n = 8). In contrast, in tissues taken from virus‐infected mice at day 4 post‐inoculation, BQ‐123 caused a marked 9.6 fold rightward shift in the concentration‐effect curve to endothelin‐1 (n = 4).
In summary, we have demonstrated that parainfluenza‐1 infection in mice transiently reduced the density of tracheal airway smooth muscle ETB receptors and this was reflected in reduced responsiveness to the ETB receptor‐selective agonist sarafotoxin S6c. In contrast, whilst parainfluenza‐1 infection in rats was associated with the pathological features and bronchial hyperresponsiveness common to respiratory tract viral infection, there was no selective down‐regulation of ETB receptor expression or functional activity. The reasons for these species differences are not clear, but may relate to differences in the airway inflammatory response to parainfluenza‐1 virus.